MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Johnson & Johnson Company Profile (NYSE:JNJ)

Consensus Ratings for Johnson & Johnson (NYSE:JNJ) (?)
Ratings Breakdown: 1 Sell Rating(s), 11 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Hold (Score: 2.38)
Consensus Price Target: $112.85 (4.55% downside)

Analysts' Ratings History for Johnson & Johnson (NYSE:JNJ)
Show:
DateFirmActionRatingPrice TargetActions
6/14/2016Jefferies GroupReiterated RatingHold$108.00 -> $109.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016Goldman SachsSet Price TargetNeutral$121.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Wells FargoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2016BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2016Raymond JamesReiterated RatingOutperform$120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2016Standpoint ResearchInitiated CoverageSell$94.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Deutsche BankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Bank of AmericaReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Morgan StanleyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Credit SuisseReiterated RatingHold$112.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016Piper JaffrayBoost Price TargetNeutral$105.00 -> $106.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016ArgusBoost Price TargetBuy$116.00 -> $130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016BarclaysReiterated RatingOverweight$115.00 -> $120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016RBC CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016Societe GeneraleInitiated CoverageHold$113.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016Independent Research GmbHSet Price TargetNeutral$108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015Atlantic SecuritiesInitiated CoverageNeutral$95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2015S&P Equity ResearchReiterated RatingBuy$120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2015Cowen and CompanyReiterated RatingOutperform$114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageNeutral$115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2014Sanford C. BernsteinDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/5/2014BMO Capital MarketsInitiated CoverageOutperform$118.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/16/2014Citigroup Inc.Reiterated RatingBuy$117.00 -> $122.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Johnson & Johnson (NYSE:JNJ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/12/2016        
4/19/2016Q116$1.65$1.68$17.50 billion$17.50 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2016Q415$1.42$1.44$17.88 billion$17.80 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/13/2015Q315$1.45$1.49$17.47 billion$17.10 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/14/2015Q215$1.69$1.71$17.76 billion$17.80 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/14/2015Q115$1.54$1.56$17.40 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/20/2015Q414$1.26$1.27$18.59 billion$18.30 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/14/2014Q314$1.43$1.50$18.41 billion$18.50 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/15/2014Q214$1.54$1.66$18.86 billion$19.50 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/15/2014Q114$1.48$1.54$18.00 billion$18.10 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/21/2014Q413$1.20$1.24$17.95 billion$18.40 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/15/2013Q313$1.32$1.36$17.46 billion$17.60 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/16/2013Q2 2013$1.39$1.48$17.71 billion$17.90 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/16/2013Q1 2013$1.41$1.44$17.46 billion$17.50 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/22/2013Q4 2012$1.17$1.19$17.67 billion$17.60 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/16/2012$1.21$1.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2012$1.29$1.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/17/2012$1.34$1.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/24/2012$1.09$1.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/18/2011$1.21$1.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/19/2011$1.24$1.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2011$1.26$1.35ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/25/2011$1.03$1.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Johnson & Johnson (NYSE:JNJ)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$1.60$1.67$1.64
Q2 20162$1.64$1.68$1.66
Q3 20161$1.60$1.60$1.60
Q4 20162$1.62$1.65$1.64
Q1 20172$1.69$1.73$1.71
Q2 20172$1.74$1.81$1.78
Q3 20172$1.70$1.73$1.72
Q4 20172$1.74$1.82$1.78
(Data provided by Zacks Investment Research)
Current Dividend Information for Johnson & Johnson (NYSE:JNJ)
Annual Dividend:$3.20
Dividend Yield:2.71%
Payout Ratio:48.48%
Dividend Growth:7.10% (3 Year Average)

Dividend History for Johnson & Johnson (NYSE:JNJ)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
4/28/2016quarterly$0.805/20/20165/24/20166/7/2016Tweet This Announcement  Share This Announcement on StockTwits
1/4/2016quarterly$0.752/19/20162/23/20163/8/2016Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015quarterly$0.7511/20/201511/24/201512/8/2015Tweet This Announcement  Share This Announcement on StockTwits
7/20/2015quarterly$0.758/21/20158/25/20159/8/2015Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015quarterly$0.752.97%5/21/20155/26/20156/9/2015Tweet This Announcement  Share This Announcement on StockTwits
1/5/2015quarterly$0.702.71%2/20/20152/24/20153/10/2015Tweet This Announcement  Share This Announcement on StockTwits
10/16/2014quarterly$0.702.89%11/21/201411/25/201412/9/2014Tweet This Announcement  Share This Announcement on StockTwits
7/21/2014quarterly$0.702.73%8/22/20148/26/20149/9/2014Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014quarterly$0.702.81%5/22/20145/27/20146/10/2014Tweet This Announcement  Share This Announcement on StockTwits
1/2/2014quarterly$0.662.87%2/21/20142/25/20143/11/2014Tweet This Announcement  Share This Announcement on StockTwits
10/17/2013quarterly$0.662.88%11/22/201311/26/201312/10/2013Tweet This Announcement  Share This Announcement on StockTwits
7/15/2013quarterly$0.662.92%8/23/20138/27/20139/10/2013Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013quarterly$0.663.1%5/23/20135/28/20136/11/2013Tweet This Announcement  Share This Announcement on StockTwits
1/2/2013quarterly$0.613.45%2/22/20132/26/20133/12/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Johnson & Johnson (NYSE:JNJ)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/7/2016Gary J PrudenVPSell9,735$116.03$1,129,552.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Ronald A KapustaCAOSell3,000$115.79$347,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Ronald A KapustaCAOSell3,957$114.77$454,144.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016Paulus StoffelsinsiderSell125,000$102.43$12,803,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Peter FasoloVPSell151,385$104.12$15,762,206.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2015Ronald A. KapustaCAOSell6,239$99.68$621,903.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2015Charles PrinceDirectorBuy2,500$99.22$248,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2015Paulus StoffelsInsiderSell187,250$100.73$18,861,692.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014James CullenDirectorSell2,446$104.12$254,677.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2014Stephen CosgroveInsiderSell22,000$100.05$2,201,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2014Peter FasoloVPSell6,824$93.15$635,655.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Stephen CosgroveInsiderSell17,200$91.39$1,571,908.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Michael UllmannVPSell16,140$93.68$1,511,995.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2013Paulus StoffelsInsiderSell45,440$92.40$4,198,656.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2013Dominic J CarusoCFOSell30,000$90.31$2,709,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2012James CullenDirectorSell13,900$69.70$968,830.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Johnson & Johnson (NYSE:JNJ)
DateHeadline
06/29/16 07:36 AMJohnson & Johnson (NYSE:JNJ) close to 52-week high, short interest down - Street Report
06/29/16 07:36 AMJohnson & Johnson (JNJ) Closes 1.44% Up on the Day for June 28 - Equities.com
06/29/16 06:44 AM7:44 am Johnson & Johnson confirms ibrutinib (:IMBRUVICA) has been granted a fourth Breakthrough Therapy Designation by the FDA -
06/29/16 06:21 AM[$$] Tesaro's Cancer Drug Meets Primary Endpoint in Late-Stage Trial -
06/28/16 07:23 PMHow to Trade Earnings Season -
06/28/16 04:41 PMPrice Target Highlight: Johnson & Johnson (NYSE:JNJ) - News Oracle
06/28/16 04:41 PMNo Tears In Johnson & Johnson - Benzinga
06/28/16 04:41 PMHC Stocks Assessment: Abbott Laboratories (NYSE:ABT), Johnson & Johnson (NYSE:JNJ) - share market updates (press release)
06/28/16 02:57 PMOnline networks create programming for the digitally minded mom -
06/28/16 12:20 PMThis 5-Stock Portfolio Makes the Perfect Summer Gift -
06/28/16 09:40 AMCramer: The 3 Stocks That Will Tell You If the Rally Is Real
06/28/16 09:40 AMJohnson & Johnson: Is There An Opportunity For Growth?
06/28/16 09:03 AM5 Medical Stocks to Buy with Great Dividend Yields -
06/27/16 07:32 PMForget Financials, Buy These Consumer Staples Stocks Instead -
06/27/16 04:45 PMNo Tears In Johnson & Johnson
06/27/16 04:45 PMInteresting October Stock Options for JNJ
06/27/16 09:06 AMJohnson & Johnson Becomes #15 Most Shorted Dow Stock, Replacing Merck
06/27/16 08:41 AMThe One Stock to Immunize Your Portfolio From the Brexit Contagion -
06/26/16 12:53 PMBloodbath Bargains: The 10 Best Post-Brexit Stocks to Buy Now -
06/25/16 04:26 PMJohnson & Johnson Stock Price Update Today (JNJ) - June 25, 2016 - Money Morning
06/25/16 04:26 PMJohnson & Johnson (JNJ) Closes 1.49% Down on the Day for June 24 - Equities.com
06/25/16 07:48 AMJohnson & Johnson (JNJ) Closes 1.49% Down on the Day for June 24
06/25/16 07:28 AM3 Stocks with Better Dividends Than Procter & Gamble Co. -
06/24/16 07:46 PMJohnson & Johnson wants Pinnacle bellwethers stayed after $500m loss
06/24/16 07:46 PMHot Stock to Track – Johnson & Johnson (JNJ) unveiled Retirement of Louise Mehrotra and her replacement
06/24/16 07:20 PM3 Stocks to Help You Build Retirement Wealth -
06/24/16 02:34 PMHC Stocks Reports: Abbott Laboratories (NYSE:ABT), Johnson & Johnson (NYSE:JNJ) - share market updates (press release)
06/24/16 02:34 PMAnalysis under consideration: Johnson & Johnson (NYSE:JNJ) - News Oracle
06/24/16 12:38 PMHow Has Becton Dickinson’s Stock Performed? -
06/24/16 07:24 AMJohnson & Johnson Stock Price Update Today (JNJ) - June 24, 2016 - Money Morning
06/24/16 07:24 AMAnalysts Rating updates about two Stocks: Johnson & Johnson (NYSE:JNJ) , Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - Street Updates
06/23/16 05:09 PMActive Momentum Stocks- Celgene Corporation (NASDAQ:CELG), Johnson & Johnson (NYSE:JNJ) - Seneca Globe
06/23/16 05:09 PMJohnson & Johnson (NYSE:JNJ) & Prima BioMed (NASDAQ:PBMD) Healthcare Stock's Trend Analysis Report - Wall Street 24
06/23/16 05:09 PMJohnson & Johnson (JNJ) Closes 0.79% Up on the Day for June 23 - Equities.com
06/23/16 07:41 AMJohnson & Johnson Stock Price Update Today (JNJ) - June 21, 2016 - Money Morning
06/23/16 07:41 AMAnalyst Opinion of: Johnson & Johnson (NYSE:JNJ) - News Oracle
06/23/16 07:41 AMJohnson & Johnson (JNJ) Closes 0.24% Up on the Day for June 22 - Equities.com
06/22/16 04:52 PMHot Stock to Track - Johnson & Johnson (JNJ) unveiled Retirement of Louise Mehrotra and her replacement - Street Register
06/22/16 01:12 PMTechnology Forces Advertisers To Get Creative -
06/22/16 09:26 AMAnalyst's Stocks Ratings Trend: Johnson & Johnson (NYSE:JNJ) , Hologic, Inc. (NASDAQ:HOLX) - Street Updates
06/22/16 09:26 AMTrending Stock Analysis: Johnson & Johnson (NYSE:JNJ) - News Oracle
06/22/16 09:26 AMHC Stocks Highlights: Johnson & Johnson (NYSE:JNJ), AbbVie Inc (NYSE:ABBV) - share market updates (press release)
06/22/16 09:26 AMJohnson & Johnson (JNJ) Closes 0.31% Down on the Day for June 21 - Equities.com
06/22/16 09:26 AMJohnson & Johnson (JNJ) Closes 0.92% Up on the Day for June 20 - Equities.com
06/22/16 08:19 AMJohnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations - [at noodls] - NEW BRUNSWICK, N.J., June 22, 2016 - Johnson & Johnson (NYSE: JNJ) today announced that Louise Mehrotra, Vice President of Investor Relations for Johnson & Johnson, will retire in January 2017, after a ...
06/22/16 08:07 AMZimmer Biomet to Strengthen its Spine Business through LDR Acquisition -
06/22/16 07:16 AMJohnson & Johnson Names Joseph Wolk As VP Of Investor Relations In Place Of Louise Mehrotra - Johnson & Johnson (NYSE: JNJ) revealed Tuesday that Louise Mehrotra, VP of Investor Relations, would retire in January next year, after a transition period with her successor. According to the company, Joseph Wolk would replace the position with effect from August and would report to the CFO. Louise first joined the company in 1980, and led Investor Relations for over a decade now. Johnson & Johnson's VP and CFO, Dominic ...Full story available on Benzinga.com
06/21/16 04:28 PMHow Do Zimmer Biomet’s Valuations Compare to Peers?
06/21/16 04:28 PMJohnson & Johnson to Host Investor Conference Call on Second-Quarter Results
06/21/16 04:28 PMJohnson & Johnson, Part II - Falling Behind On Medical Devices
About Johnson & Johnson

Johnson & Johnson logoJohnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company's segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on over five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: JNJ
  • CUSIP: 47816010
Key Metrics:
  • Previous Close: $116.55
  • 50 Day Moving Average: $114.96
  • 200 Day Moving Average: $108.01
  • P/E Ratio: 21.55
  • P/E Growth: 2.94
  • Market Cap: $325.21B
  • Current Quarter EPS Consensus Estimate: $6.61 EPS
Additional Links:
Johnson & Johnson (NYSE:JNJ) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha